Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G A Grandits

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
The American Journal of Clinical Nutrition|January 1, 1997
Relation of smoking at baseline and during trial years 1-6 to food and nutrient intakes and weight in the special intervention and usual care groups in the Multiple Risk Factor Intervention TrialJ Stamler, D Rains-Clearman, K Lenz-Litzow, et al.
The American Journal of Clinical Nutrition|January 1, 1997
Food group and macronutrient intakes, trial years 1-6, in the special intervention and usual care groups in the Multiple Risk Factor Intervention TrialD D Gorder, G E Bartsch, J L Tillotson, et al.
Journal of Human Hypertension|November 30, 2012
Effect of carvedilol, lisinopril and their combination on vascular and cardiac health in patients with borderline blood pressure: the DETECT StudyS M Saul, D A Duprez, W Zhong, et al.
Controlled Clinical Trials|February 13, 2001
Obtaining event status at the close of the Treatment of Mild Hypertension Study: methods and implication for other trialsG A Grandits, R H Grimm, R J Prineas, et al.
Archives of Family Medicine|February 9, 2000
Effect of calcium supplementation on serum cholesterol and blood pressure. A randomized, double-blind, placebo-controlled, clinical trialR M Bostick, L Fosdick, G A Grandits, et al.
The American Journal of Clinical Nutrition|January 1, 1997
Nutritional adequacy of diets reported at baseline and during trial years 1-6 by the special intervention and usual care groups in the Multiple Risk Factor Intervention TrialT A Dolecek, R L Johnson, G A Grandits, et al.
Annals of Epidemiology|January 1, 1994
Insulin as a predictor of coronary heart disease: interaction with apolipoprotein E phenotype. A report from the Multiple Risk Factor Intervention TrialT J Orchard, J Eichner, L H Kuller, et al.
American Journal of Epidemiology|December 1, 1991
The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention TrialL H Kuller, J E Eichner, T J Orchard, et al.
American Journal of Hypertension|March 13, 1999
Urinary sodium and potassium profile of blacks and whites in relation to education in two different geographic urban areas. TOMHS Research Group. Treatment of Mild Hypertension StudyM C Ganguli, R H Grimm, K H Svendsen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 1, 1995
Plasma carotenoids as biomarkers of vegetable intake: the University of Minnesota Cancer Prevention Research Unit Feeding StudiesM C Martini, D R Campbell, M D Gross, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
The American Journal of Clinical Nutrition|January 1, 1997
Relation of smoking at baseline and during trial years 1-6 to food and nutrient intakes and weight in the special intervention and usual care groups in the Multiple Risk Factor Intervention TrialJ Stamler, D Rains-Clearman, K Lenz-Litzow, et al.
The American Journal of Clinical Nutrition|January 1, 1997
Food group and macronutrient intakes, trial years 1-6, in the special intervention and usual care groups in the Multiple Risk Factor Intervention TrialD D Gorder, G E Bartsch, J L Tillotson, et al.
Journal of Human Hypertension|November 30, 2012
Effect of carvedilol, lisinopril and their combination on vascular and cardiac health in patients with borderline blood pressure: the DETECT StudyS M Saul, D A Duprez, W Zhong, et al.
Controlled Clinical Trials|February 13, 2001
Obtaining event status at the close of the Treatment of Mild Hypertension Study: methods and implication for other trialsG A Grandits, R H Grimm, R J Prineas, et al.
Archives of Family Medicine|February 9, 2000
Effect of calcium supplementation on serum cholesterol and blood pressure. A randomized, double-blind, placebo-controlled, clinical trialR M Bostick, L Fosdick, G A Grandits, et al.
The American Journal of Clinical Nutrition|January 1, 1997
Nutritional adequacy of diets reported at baseline and during trial years 1-6 by the special intervention and usual care groups in the Multiple Risk Factor Intervention TrialT A Dolecek, R L Johnson, G A Grandits, et al.
Annals of Epidemiology|January 1, 1994
Insulin as a predictor of coronary heart disease: interaction with apolipoprotein E phenotype. A report from the Multiple Risk Factor Intervention TrialT J Orchard, J Eichner, L H Kuller, et al.
American Journal of Epidemiology|December 1, 1991
The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention TrialL H Kuller, J E Eichner, T J Orchard, et al.
American Journal of Hypertension|March 13, 1999
Urinary sodium and potassium profile of blacks and whites in relation to education in two different geographic urban areas. TOMHS Research Group. Treatment of Mild Hypertension StudyM C Ganguli, R H Grimm, K H Svendsen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 1, 1995
Plasma carotenoids as biomarkers of vegetable intake: the University of Minnesota Cancer Prevention Research Unit Feeding StudiesM C Martini, D R Campbell, M D Gross, et al.
Pageof 4